Dr. Jeff Bradstreet discusses: Recent studies suggest abnormal cannabinoid receptor type 2 (CB2) signalling in peripheral blood mononuclear cells (PBMCs) extracted from autistic children, implying the endocannabinoid system could be functionally involved in ASD-mediated immune impairments. Cannabinoid 1 receptors are … Continue reading →